Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
Stanley S SchwartzDiabetes Disease Management at the University of Pennsylvania, Penn Presbyterian Medical Center, Philadelphia Heart Institute, Philadelphia, Pennsylvania, USAAbstract: Insulin resistance and impaired beta-cell function are primary defects that occur early in the course of developme...
Saved in:
Main Author: | Schwartz S |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2010
|
Subjects: | |
Online Access: | https://doaj.org/article/33e4a4e1bbd24cc692ca6be2cb52a8c4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications
by: Wondmkun YT
Published: (2020) -
Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
by: Stanley S Schwartz
Published: (2010) -
Diabetes autoinmune (latente) del adulto
by: Pollak C,Felipe, et al.
Published: (2012) -
The Association Between Insulin Resistance, Leptin, and Resistin and Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients with Different Body Mass Indexes
by: Huang J, et al.
Published: (2021) -
Achieving Effective and Efficient Basal Insulin Optimal Management by Using Mobile Health Application (APP) for Type 2 Diabetes Patients in China
by: Cai X, et al.
Published: (2020)